Impurity reference standards
Pazopanib impurities & reference standards
Characterised Pazopanib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
37reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
2,3-Dimethyl-6-(methyl(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)amino)-2H-indazole 2-oxide
- CAS
- 1821666-74-3
- Formula
- C21H23N7O3S
- MW
- 453.5 g/mol
VQ-043606
5-((4-((1,3-Dimethyl-1H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
- CAS
- 2369664-25-3
- Formula
- C21H23N7O2S
- MW
- 437.5 g/mol
VQ-033081
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonic Acid
- CAS
- 2795176-90-6
- Formula
- C21H22N6O3S
- MW
- 438.5 g/mol
VQ-041363
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-N-((5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylphenyl)sulfonyl)-2-methylbenzenesulfonamide
- CAS
- 2095544-42-4
- Formula
- C42H43N13O4S2
- MW
- 858 g/mol
VQ-041361
5-Amino-N-(4-(bis(5-amino-2-methylphenyl)methyl)phenyl)-2-methylbenzenesulfonamide
- CAS
- 1226500-00-0
- Formula
- C28H30N4O2S
- MW
- 486.6 g/mol
VQ-044405
N-(2-Methoxypyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine
- CAS
- 1296888-47-5
- Formula
- C15H17N5O
- MW
- 283.33 g/mol
VQ-027403
N-(4-Chloropyrimidin-2-yl)-2,3-dimethyl-2H-indazol-6-amine
- CAS
- 1226499-97-3
- Formula
- C13H12ClN5
- MW
- 273.72 g/mol
VQ-041364
N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine Oxide
- CAS
- 1821666-73-2
- Formula
- C21H23N7O3S
- MW
- 453.5 g/mol
VQ-043605
N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)pyrimidine-2,4-diamine
- CAS
- 1226500-02-2
- Formula
- C26H23ClN10
- MW
- 511 g/mol
VQ-027404
N2,N4-Bis(2,3-dimethyl-2H-indazol-6-yl)-2,4-pyrimidinediamine
- CAS
- 1226499-98-4
- Formula
- C22H22N8
- MW
- 398.5 g/mol
VQ-033080
N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine
- CAS
- 1821666-71-0
- Formula
- C14H16N6
- MW
- 268.32 g/mol
VQ-033079
FAQs — Pazopanib impurities
Which Pazopanib impurities do you supply?
We list 37 Pazopanib-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Pazopanib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Pazopanib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Pazopanib impurity standards
We reply within one business day with price, pack options, lead time and documentation.